Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01937052 · ClinicalTrials.gov registry record

Johns Hopkins Breast Cancer Program Hormone Therapy Longitudinal Database

A clinical trial, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

Completed
Registry status
329
Enrollment target

NCT01937052 is a clinical trial that has completed, run by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. The registered enrollment target is 329 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01937052 has completed, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

COMPLETED
Registry status
329 participants
Enrollment target

Study Summary

The purpose of this project is to establish a repository of information and samples from breast cancer patients or those at high risk of developing breast cancer, who are initiating hormone therapy as part of standard clinical care or prevention. This repository will include patient reported outcomes and other questionnaires, information on medication use, data about adherence to the hormone therapy and tumor characteristics, including prospectively collected samples.

Interventions

  • OTHER Sample collection
  • BEHAVIORAL Patient-reported outcomes

Trial Details

FieldValue
Enrollment Target 329 participants
Start Date 2012-05-09
Est. Completion 2024-11-25

What the Registry Record Tells You About NCT01937052

The ClinicalTrials.gov registry entry for NCT01937052 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 329 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Sample collection is the first listed.

NCT01937052 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01937052 about?

NCT01937052 is a clinical study titled "Johns Hopkins Breast Cancer Program Hormone Therapy Longitudinal Database". The purpose of this project is to establish a repository of information and samples from breast cancer patients or those at high risk of developing breast cancer, who are initiating hormone therapy as part of standard clinical care or prevention. This repository will include patient reported outcome...

What is the current status of trial NCT01937052?

This trial is currently completed. The enrollment target is 329 participants. The study started on 2012-05-09. Estimated completion is 2024-11-25.

What interventions are being tested in trial NCT01937052?

The interventions under investigation include: Sample collection (OTHER), Patient-reported outcomes (BEHAVIORAL).

Who is sponsoring clinical trial NCT01937052?

This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.